Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 11 | $641,940 |
Sells | 126 | $5,108,688 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
27 Oct 2022 18:49 | TRDA | Entrada Therapeutics Inc | KREHER NERISSA | Chief Medical Officer | 26 Oct 2022 | Sale | 643 | 21.2104 | 13,638 | D |
12 Sep 2022 16:14 | TRDA | Entrada Therapeutics Inc | DOWDEN NATHAN J | Chief Operating Officer | 09 Sep 2022 | Sale | 865 | 15.0646 | 13,031 | D |
06 Sep 2023 17:07 | TRDA | Entrada Therapeutics Inc | DOWDEN NATHAN J | Chief Operating Officer | 06 Sep 2023 | Sale | 913 | 13.4312 | 12,263 | D |
06 Sep 2023 17:11 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 06 Sep 2023 | Sale | 904 | 13.4522 | 12,161 | D |
12 Sep 2022 16:18 | TRDA | Entrada Therapeutics Inc | KREHER NERISSA | Chief Medical Officer | 09 Sep 2022 | Sale | 800 | 15.0669 | 12,054 | D |
06 Sep 2023 17:08 | TRDA | Entrada Therapeutics Inc | KREHER NERISSA | Chief Medical Officer | 06 Sep 2023 | Sale | 871 | 13.4647 | 11,728 | D |
21 Mar 2024 16:31 | TRDA | Entrada Therapeutics Inc | KIM PETER S | Director | 19 Mar 2024 | Purchase | 900 | 12.6633 | 11,397 | D |
12 Sep 2022 16:21 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 09 Sep 2022 | Sale | 688 | 15.0669 | 10,366 | D |
21 Mar 2024 16:31 | TRDA | Entrada Therapeutics Inc | KIM PETER S | Director | 21 Mar 2024 | Purchase | 704 | 13.2353 | 9,318 | D |
29 Dec 2022 16:51 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 27 Dec 2022 | Sale | 600 | 14.7989 | 8,879 | D |
31 Aug 2022 16:55 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 29 Aug 2022 | Sale | 505 | 13.5097 | 6,822 | D |
29 Dec 2022 16:51 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 29 Dec 2022 | Sale | 400 | 15.0128 | 6,005 | D |
28 Sep 2022 17:10 | TRDA | Entrada Therapeutics Inc | KREHER NERISSA | Chief Medical Officer | 26 Sep 2022 | Sale | 300 | 16.33 | 4,899 | D |
28 Sep 2022 17:12 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 26 Sep 2022 | Sale | 288 | 16.3028 | 4,695 | D |
26 Aug 2022 16:06 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 24 Aug 2022 | Sale | 301 | 14.227 | 4,282 | D |
18 Nov 2022 16:59 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 16 Nov 2022 | Sale | 200 | 18.1 | 3,620 | D |
06 Dec 2022 17:02 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 05 Dec 2022 | Sale | 200 | 18.05 | 3,610 | D |
28 Sep 2022 17:08 | TRDA | Entrada Therapeutics Inc | DOWDEN NATHAN J | Chief Operating Officer | 26 Sep 2022 | Sale | 215 | 16.2477 | 3,493 | D |
29 Mar 2023 17:12 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 27 Mar 2023 | Sale | 200 | 15.51 | 3,102 | D |
19 Sep 2022 16:35 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 15 Sep 2022 | Sale | 200 | 15.04 | 3,008 | D |
23 Aug 2022 18:28 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 22 Aug 2022 | Sale | 217 | 13.0047 | 2,822 | D |
18 Aug 2022 18:53 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 17 Aug 2022 | Sale | 200 | 13.07 | 2,614 | D |
18 Aug 2022 18:53 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 18 Aug 2022 | Sale | 200 | 13 | 2,600 | D |
18 Aug 2022 18:53 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 16 Aug 2022 | Sale | 200 | 13 | 2,600 | D |
31 Aug 2022 16:55 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 30 Aug 2022 | Sale | 190 | 12 | 2,280 | D |
27 Oct 2022 18:49 | TRDA | Entrada Therapeutics Inc | KREHER NERISSA | Chief Medical Officer | 25 Oct 2022 | Sale | 100 | 22.13 | 2,213 | D |
31 Aug 2022 16:55 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 31 Aug 2022 | Sale | 171 | 12 | 2,052 | D |
03 Mar 2023 16:32 | TRDA | Entrada Therapeutics Inc | KREHER NERISSA | Chief Medical Officer | 02 Mar 2023 | Sale | 164 | 11.2227 | 1,841 | D |
03 Mar 2023 16:37 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 02 Mar 2023 | Sale | 145 | 11.2282 | 1,628 | D |
19 Sep 2022 16:32 | TRDA | Entrada Therapeutics Inc | KREHER NERISSA | Chief Medical Officer | 15 Sep 2022 | Sale | 106 | 15.0134 | 1,591 | D |
26 Dec 2023 16:35 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 26 Dec 2023 | Sale | 94 | 16.67 | 1,567 | D |
19 Sep 2022 16:34 | TRDA | Entrada Therapeutics Inc | DOWDEN NATHAN J | Chief Operating Officer | 15 Sep 2022 | Sale | 100 | 15.01 | 1,501 | D |
04 Aug 2023 16:50 | TRDA | Entrada Therapeutics Inc | KREHER NERISSA | Chief Medical Officer | 02 Aug 2023 | Sale | 68 | 16.82 | 1,144 | D |
06 Sep 2023 17:07 | TRDA | Entrada Therapeutics Inc | DOWDEN NATHAN J | Chief Operating Officer | 06 Sep 2023 | Sale | 59 | 14.0069 | 826 | D |
06 Sep 2023 17:11 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 06 Sep 2023 | Sale | 46 | 14.03 | 645 | D |
31 Aug 2022 16:55 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 29 Aug 2022 | Sale | 25 | 14 | 350 | D |
06 Sep 2023 17:08 | TRDA | Entrada Therapeutics Inc | KREHER NERISSA | Chief Medical Officer | 06 Sep 2023 | Sale | 21 | 14 | 294 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)